Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with type 2 diabetes mellitus.

被引：0
|
作者：
Sidharta, Patricia N.
Rave, Klaus
Heise, Tim
Chiossi, Eleonora
Dingemanse, Jasper
机构：
[1] Actelion Pharmaceut Ltd, Allschwil, Switzerland
[2] Profil Inst Stoffwechselforsch GmbH, Neuss, Germany
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
93
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 50 条
  • [1] Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus
    Sidharta, Patricia N.
    Rave, Klaus
    Heinemann, Lutz
    Chiossi, Eleonora
    Kraehenbuehl, Stephan
    Dingemanse, Jasper
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (04) : 502 - 510
  • [2] Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in macroalbuminuric, diabetic patients.
    Sidharta, PN
    Wagner, FD
    Jungik, A
    Halabi, A
    Dingemanse, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1078 - 1078
  • [3] Pharmacokinetics and Pharmacodynamics of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (10): : 1168 - 1175
  • [4] Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy human subjects
    Sidharta, PN
    van Giersbergen, PLM
    Schaarschmidt, D
    Dingemanse, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1192 - 1192
  • [5] Effect of the Urotensin Receptor Antagonist Palosuran in Hypertensive Patients With Type 2 Diabetic Nephropathy
    Vogt, Liffert
    Chiurchiu, Carlos
    Chadha-Boreham, Harbajan
    Danaietash, Parisa
    Dingemanse, Jasper
    Hadjadj, Samy
    Krum, Henry
    Navis, Gerjan
    Neuhart, Eric
    Parvanova, Aneliya I.
    Ruggenenti, Piero
    Woittiez, Arend Jan
    Zimlichman, Reuven
    Remuzzi, Giuseppe
    de Zeeuw, Dick
    HYPERTENSION, 2010, 55 (05) : 1206 - 1209
  • [6] The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats
    Clozel, M
    Hess, P
    Qiu, CB
    Ding, SS
    Rey, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03): : 1115 - 1121
  • [7] Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.
    Pavo, I
    Herz, M
    Tan, M
    Shestakova, MV
    Smirnova, OM
    Jermendy, G
    Kerenyi, Z
    Widel, MH
    Schluchter, BJ
    Johns, D
    DIABETOLOGIA, 2002, 45 : A250 - A250
  • [8] Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients
    Sidharta, Patricia N.
    Wagner, Frank D.
    Bohnemeier, Holger
    Jungnik, Arvid
    Halabi, Atef
    Kraehenbuehl, Stephan
    Chadha-Boreham, Harbajan
    Dingemanse, Jasper
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 246 - 256
  • [9] Improved insulin secretion and sensitivity by Glimepiride in new onset Type 2 Diabetes Mellitus.
    Kabadi, UM
    Kabadi, MU
    DIABETOLOGIA, 2001, 44 : A216 - A216
  • [10] Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    PHARMACOLOGY, 2018, 102 (5-6) : 339 - 346
12345